Clusterization of Inositol Trisphosphate Receptors Determines the Shape of the Calcium Oscillation Peak in Platelet Cytosol


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription Access

Abstract

Platelets, which are anucleate blood cells, should have the capacity to respond to an external stimulus within 1 second. This capacity is maintained by calcium signaling, the process of intracellular signal transmission mediated by an increase of the calcium ion concentration in the cytosol due to calcium release from the endoplasmic reticulum through the inositol trisphosphate receptor channel (IP3R). The increase of the calcium concentration in the platelet cytosol is not monotonous, but rather has an oscillatory character, similar to the processes in many other cell types. The regularities that underlie the development of these oscillations were subjected to theoretical and experimental analysis in the present study. Total internal reflection microscopy of platelets immobilized on fibrinogen and loaded with the Fura-2 calcium-sensitive fluorescent label was used to monitor the dynamics of calcium concentration. The mathematical model of the IP3R–ATPase pair from [15] modified to take the platelet parameters into account was used to describe the process of oscillation development. The results of the study demonstrated a characteristic peak shape for calcium oscillations in the platelet: theoretical description of the peak shape essentially required the introduction of corrections that had the physical meaning of cooperative IP3R activation.

About the authors

F. A. Balabin

Center for Theoretical Problems of Physicochemical Pharmacology, Russian Academy of Sciences

Author for correspondence.
Email: fa.balabin@physics.msu.ru
Russian Federation, Moscow, 119991

D. S. Morozova

Department of Fundamental Medicine, Moscow State University

Email: fa.balabin@physics.msu.ru
Russian Federation, Moscow, 119991

A. S. Mayorov

Center for Theoretical Problems of Physicochemical Pharmacology, Russian Academy of Sciences; Department of Physics, Moscow State University; Rogachev National Medical Research Center of Pediatric Hematology, Oncology, and Immunology

Email: fa.balabin@physics.msu.ru
Russian Federation, Moscow, 119991; Moscow, 119991; Moscow, 117997

A. A. Martyanov

Center for Theoretical Problems of Physicochemical Pharmacology, Russian Academy of Sciences; Department of Physics, Moscow State University; Rogachev National Medical Research Center of Pediatric Hematology, Oncology, and Immunology

Email: fa.balabin@physics.msu.ru
Russian Federation, Moscow, 119991; Moscow, 119991; Moscow, 117997

M. A. Panteleev

Center for Theoretical Problems of Physicochemical Pharmacology, Russian Academy of Sciences; Department of Physics, Moscow State University; Rogachev National Medical Research Center of Pediatric Hematology, Oncology, and Immunology

Email: fa.balabin@physics.msu.ru
Russian Federation, Moscow, 119991; Moscow, 119991; Moscow, 117997

A. N. Sveshnikova

Center for Theoretical Problems of Physicochemical Pharmacology, Russian Academy of Sciences; Department of Physics, Moscow State University; Rogachev National Medical Research Center of Pediatric Hematology, Oncology, and Immunology

Email: fa.balabin@physics.msu.ru
Russian Federation, Moscow, 119991; Moscow, 119991; Moscow, 117997

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2018 Allerton Press, Inc.